Newsletter | October 5, 2026

10.05.26 -- FDA Finalizes Psychedelic Drug Guidance: What Sponsors Need To Know

SPONSOR

 

 

CNS Summit 2026, the life sciences leadership community, will be held November 1–4 at the Encore Boston Harbor. It will feature thoughtfully curated programming designed to inspire innovation, collaboration, and partnerships. Apply to join the community where life sciences leaders gain access to the networking and knowledge they need to succeed.

VIDEO

Shaping Drug Development by Starting with the Disease with Roche's Sylke Poehling, Ph.D.

In episode 137 of Cell & Gene: The Podcast, Host Erin Harris talks with Sylke Poehling, Ph.D., SVP and Global Head: Therapeutic Modalities, pRED; Roche Gene Therapy Center of Excellence about how the company selects the optimal modality by starting with disease biology.

 

INDUSTRY INSIGHTS

 

Validation Beyond Just Meeting FDA Requirements Is Crucial

As the U.S. FDA is impacted by layoffs that threaten its oversight capabilities, the importance of robust software and manufacturing process validation has never been more critical.

 

FDA Finalizes Psychedelic Drug Guidance: What Sponsors Need To Know

FDA's July 2026 final guidance on psychedelic drug clinical investigations sets expectations for sponsors developing psilocybin, LSD, and MDMA therapies. Discover what it means for your program.

 

Operationalizing Immuno-Oncology Studies

Managing CRS and immune risks demands early detection, rapid response, and skilled teams. Strong infrastructure and clear protocols enable safer immunotherapy trials beyond academic centers.

 

Optimized Residual dsRNA Detection For mRNA Therapeutics

In the field of mRNA therapeutics, residual double-stranded RNA (dsRNA) remains a significant safety concern. Learn how an optimized dsRNA detection method helps improve quality and safety in mRNA-based drugs.

 

The AI-Ready Factory: How IT/OT Integration Transforms Manufacturing Data

Pharmaceutical manufacturers need more than raw production data to scale AI. Learn how contextualized, governed IT/OT integration can turn disconnected shop-floor signals into real-time decisions.

 

A Diverse Talent Pool And Rich Resource Base

This group offers life sciences organizations a deep talent pool, an extensive R&D presence, and dedicated backing by local government investment.
Connect With Life Science Leader: